CIK 0001610853
- Non-accelerated filer
- Smaller reporting company
Solana Co
Sign in to watch- Ticker
- HSDT
- Exchange
- Nasdaq
- Industry
- Finance Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 364787690
- Phone
- +1 215-944-6100
- Business address
- 1650 MARKET STREET, SUITE 3600, PHILADELPHIA, PA, 19103
- Former names
- HELIUS MEDICAL TECHNOLOGIES, INC., HELIUS MEDICAL TECHNOLOGIES, INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-01-31 | Deschamps Philippe President and CEO | Grant or award | +3,959 | $1.01 | $4K | 37,007 |
| 2020-01-15 | LaViscount Joyce N CFO and COO | Grant or award | +2,639 | $1.04 | $3K | 37,569 |
| 2020-01-15 | Deschamps Philippe President and CEO | Grant or award | +3,844 | $1.04 | $4K | 33,048 |
| 2019-12-31 | LaViscount Joyce N CFO and COO | Grant or award | +2,830 | $0.97 | $3K | 34,930 |
| 2019-12-31 | Deschamps Philippe President and CEO | Grant or award | +4,122 | $0.97 | $4K | 29,204 |
| 2019-12-13 | LaViscount Joyce N CFO and COO | Grant or award | +6,239 | $0.44 | $3K | 32,100 |
| 2019-12-13 | Deschamps Philippe President and CEO | Grant or award | +9,087 | $0.44 | $4K | 25,082 |
| 2019-12-07 | GRIFFIN THOMAS E Director | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2019-12-07 | GRIFFIN THOMAS E Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-12-07 | Deschamps Philippe President and CEO | Returned to the company · Employee Stock Option (Right to Buy) | −300,000 | 0 | ||
| 2019-12-07 | Deschamps Philippe President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2019-12-07 | Walter Blane Director | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2019-12-07 | Walter Blane Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-12-07 | Walter Blane Director | Returned to the company · Stock Option (Right to Buy) | −20,000 | 0 | ||
| 2019-12-07 | Walter Blane Director | Grant or award · Stock Option (Right to Buy) | +20,000 | 20,000 | ||
| 2019-12-07 | Peng Huaizheng Director | Returned to the company · Stock Option (Right to Buy) | −10,000 | 0 | ||
| 2019-12-07 | Peng Huaizheng Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2019-12-07 | Peng Huaizheng Director | Returned to the company · Stock Option (Right to Buy) | −15,000 | 0 | ||
| 2019-12-07 | Peng Huaizheng Director | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2019-12-07 | LaViscount Joyce N CFO and COO | Returned to the company · Employee Stock Option (Right to Buy) | −20,000 | 0 |
Page 13 of 18 · 360 trades